Trial intelligence / Profile preview

Sequential Therapy Duration for H. pylori

NCT01042184Phase 4Completed

Sponsor
National Taiwan University Hospital
Start
Dec 2009
Primary completion
Feb 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of metronidazole in Helicobacter pylori infection, sponsored by National Taiwan University Hospital. Started Dec 2009; status: completed.

02

Drugs

metronidazole
03

Conditions

Helicobacter pylori infection

Beyond the preview

Go deeper on NCT01042184.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01042184.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call